The Centers for Disease Control and Prevention on Thursday gave final approval for certain people to receive booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines.
The agency also approved the option of mixing and matching, so people can receive a booster from a different manufacturer than their initial dose.
Those who are eligible for the Moderna booster — including people 65 and older, nursing home residents, and those 50 and up who are at severe risk if they become infected by COVID-19 — and all Johnson & Johnson vaccine recipients can sign up for boosters starting Friday. For Moderna, recipients can get a half-dose booster six months after being fully vaccinated, while those who got the single-dose Johnson & Johnson vaccine can get a booster at least two months later.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"These past 20 months have taught us many things, but mostly to have humility," CDC Director Dr. Rochelle Walensky said. "We are constantly learning about this virus, growing the evidence base and accumulating more data."
On Wednesday, the Food and Drug Administration authorized booster doses of the vaccines, followed by a CDC advisory panel earlier Thursday, leaving Walensky to make the final call on Thursday night.
-
Critics’ choice: Watering holes for gourmandsFeature An endless selection of Mexican spirits, a Dublin-inspired bar, and an upscale Baltimore pub
-
Argentinian beef is at the center of American farmers’ woesThe Explainer ‘It feels like a slap in the face to rural America,’ said one farmer
-
‘Businesses that lose money and are uncompetitive won’t survive’Instant Opinion Opinion, comment and editorials of the day
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
Why are autism rates increasing?The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defectsThe Explainer The virus can show no symptoms in adults
